Factor associated with adherence | Explanation | Evidence |
---|---|---|
Experience of side effectsa | Barrier: Increased frequency and intensity of side effects | |
Medication beliefsa | Facilitator: more beliefs about the necessity of AET Barrier: more concerns about AET | |
Illness perceptionsa | Facilitators: beliefs that certain lifestyle behaviours can cause a recurrence Barriers: low risk perception of recurrence, high tamoxifen consequences, belief that psychological factors cause a recurrence | |
Knowledge/ information availablea | Barriers: Lack of knowledge of side effects and the mechanisms of AET | [39] |
Psychological distressa | Barriers: Increased distress (including depression and anxiety) | |
Forgetfulnessa | Barriers: forgetting to take medication, memory difficulties | |
Social support | Facilitators: Increased social support | |
Self-efficacy | Facilitators: Increased self-efficacy | |
Patient-physician communication | Facilitators: Better patient-physician relationship |